If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

  • There is currently no data for IDOX

Half Year 2023 Trading Update

18 May 2023 07:00

RNS Number : 7856Z
IDOX PLC
18 May 2023
 

18 May 2023

Idox plc

('Idox' or the 'Group' or the 'Company')

Half Year 2023 Trading Update

Good first half performance, positive momentum and continued cash generation

 

Idox plc (AIM: IDOX), a leading supplier of specialist information management software and solutions to the public and asset intensive sectors, today issues a trading update for its financial half year ended 30 April 2023 ('FY23 H1').

 

 

Group trading performance

 

We are pleased to report that the Group has delivered a good performance during the first six months of the year with year-on-year adjusted EBITDA growth of c.10%. Operating under a new tripartite divisional structure of Land, Property & Public Protection, Communities and Assets, the Group continues to make encouraging progress in its chosen markets.

 

The Group delivered a significant increase in order intake during the period of c.£52m (up 23% from FY22 H1) providing good levels of recurring revenue visibility for the remainder of FY23 and into FY24.

 

The Board expects to report a c.10% increase in adjusted EBITDA to c.£12m, in line with management expectations. Revenue was up c.8% to c.£36m, within which recurring revenue was up c.7% over the period to c.£21m.

 

The Group continued to generate strong cash flow during the period and ended the half with a net cash position of c.£1m compared to a net debt position of £6.7m as at 31 October 2022 (net debt of £3.8m as at 30 April 2022).

 

 

David Meaden, Chief Executive of Idox commented:

 

"The Group has delivered a good performance for the period in a challenging macro-economic environment.

 

We have continued to secure both new clients and new contracts with key customers, which has resulted in significantly higher order intake, providing good visibility into the future. As anticipated, the Group has delivered double digit profit growth in the period.

 

Our focus on cash generation has ensured we ended the period with net cash, compared to net debt at the year end. Combined with our available debt facilities, this enables us to continue to pursue attractive acquisition targets that we believe will generate value for all shareholders.

 

We are pleased with our progress and momentum and are on track to deliver on our plans for the remainder of 2023."

 

 

Notice of half year results

 

The Group expects to report its FY23 H1 results on Thursday 8 June 2023. Management will host a results webinar on the day. Please contact MHP to register your interest.

 

 

1 Adjusted EBITDA is defined as earnings before amortisation, depreciation, restructuring, acquisition costs, impairment, financing costs and share option costs.

 

2 Net cash / (debt) is defined as the aggregation of cash, bank borrowings and long-term bond.

 

 

For further information please contact:

 

Idox plc

+44 (0) 870 333 7101

Chris Stone, Non-Executive Chairman

David Meaden, Chief Executive

Anoop Kang, Chief Financial Officer

 

investorrelations@idoxgroup.com

Peel Hunt LLP (NOMAD and Broker)

+44 (0) 20 7418 8900

Paul Gillam

Michael Burke

James Smith

 

MHP

+ 44 (0) 20 3128 8170

Reg Hoare 

Ollie Hoare

Matthew Taylor

idox@mhpgroup.com

 

 

About Idox plc

For more information see www.idoxgroup.com @Idoxgroup

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTZZGMKVNZGFZM
Date   Source Headline
31st Mar 20257:00 amRNS2025 AGM Trading update
18th Mar 20259:11 amRNSHolding(s) in Company
17th Mar 20257:00 amRNSEstablishment of EBT and Total Voting Rights
13th Mar 202510:48 amRNSHolding(s) in Company
10th Mar 20253:25 pmRNSHolding(s) in Company
7th Mar 20252:39 pmRNSDirector/PDMR Shareholding
4th Mar 20257:00 amRNSPosting of Annual Report and Notice of AGM
24th Feb 20252:36 pmRNSHolding(s) in Company
24th Feb 20257:01 amRNSHolding(s) in Company
24th Feb 20257:00 amRNSHolding(s) in Company
19th Feb 20257:00 amRNSCorrection of payment date for dividend
10th Feb 20257:00 amRNSAppointment of Senior Independent Director
28th Jan 20257:00 amRNSFinal Results
14th Jan 20257:00 amRNSNotice of Final Results
6th Jan 20257:00 amRNS-RIdox Secures Election Services Contract in Malta
20th Dec 202410:43 amRNSHolding(s) in Company
26th Nov 20247:00 amRNSFull Year 2024 Trading Update
13th Nov 202411:55 amRNSHolding(s) in Company
12th Nov 202410:09 amRNSHolding(s) in Company
28th Oct 20244:49 pmRNSHolding(s) in Company
25th Oct 20247:16 amRNSDirectorate Change
27th Sep 20243:26 pmRNSHolding(s) in Company
25th Sep 20244:28 pmRNSHolding(s) in Company
23rd Sep 20244:00 pmRNSHolding(s) in Company
2nd Sep 20243:42 pmRNSHolding(s) in Company
21st Aug 20245:30 pmRNSExercise of Share Options & Total Voting Rights
7th Aug 20245:20 pmRNSHolding(s) in Company
6th Aug 20242:51 pmRNSHolding(s) in Company
29th Jul 20247:00 amRNSDirector Appointment
11th Jun 20247:00 amRNSHalf Year Results
6th Jun 20247:00 amRNSExercise of Share Options & Total Voting Rights
24th May 20243:06 pmRNSHolding(s) in Company
22nd May 20247:00 amRNSHalf Year 2024 Trading Update
9th May 20247:00 amRNSIssue and Allotment of Consideration Shares
24th Apr 20247:00 amRNSReplacement: Total Voting Rights
17th Apr 202412:43 pmRNSTotal Voting Rights
28th Mar 20245:22 pmRNSHolding(s) in Company
28th Mar 202412:37 pmRNSDirector/PDMR Shareholding
28th Mar 202411:21 amRNSResult of AGM
28th Mar 20247:00 amRNSAGM Trading update
22nd Mar 20245:42 pmRNSDirector/PDMR Shareholding
18th Mar 20247:00 amRNSTotal Voting Rights
11th Mar 20248:40 amRNSHolding(s) in Company
8th Mar 20247:00 amRNSDirector/PDMR Shareholding
5th Mar 20245:12 pmRNSPosting of Annual Report and Notice of AGM
14th Feb 20241:39 pmRNSHolding(s) in Company
9th Feb 20247:00 amRNSExercise of Share Options & Total Voting Rights
25th Jan 20247:00 amRNSFinal Results
18th Jan 202412:35 pmRNSNotice of Final Results
17th Jan 20247:00 amRNSExercise of Share Options & Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.